Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells. (Q51028658)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2004

Language	Label	Description	Also known as
English	Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.	scientific article published in April 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

0 references

1 reference

based on heuristic

inferred from title

author name string

Kloosterboer FM

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

van Luxemburg-Heijs SA

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

van Soest RA

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

Barbui AM

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

van Egmond HM

5

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

Strijbosch MP

6

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

Kester MG

7

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

Marijt WA

8

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

Goulmy E

9

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

Willemze R

10

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

Falkenburg JH

11

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

18

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

798-808

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

Cellular therapy: donor lymphocyte infusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Nonmyeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Human minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Functional expression of minor histocompatibility antigens on human peripheral blood dendritic cells and epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Peptide-MHC class I tetrameric complexes display exquisite ligand specificity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

The progenitor cell inhibition assay to measure the anti-leukemic reactivity of T cell clones against acute and chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Identification of a graft versus host disease-associated human minor histocompatibility antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

21 January 2018

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

7 January 2021

based on heuristic

inferred from DOI database lookup

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

7 January 2021

based on heuristic

inferred from DOI database lookup

In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

7 January 2021

based on heuristic

inferred from DOI database lookup

Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

7 January 2021

based on heuristic

inferred from DOI database lookup

A case of isodicentric 7p as sole abnormality in a patient with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

7 January 2021

based on heuristic

inferred from DOI database lookup

Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-4 down-regulates IL-2-, IL-3-, and GM-CSF-induced cytokine gene expression in peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

7 January 2021

based on heuristic

inferred from DOI database lookup

Exclusive TCRVβ chain usage of ex vivo generated minor Histocompatibility antigen HA-1 specific cytotoxic T cells: implications for monitoring of immunotherapy of leukemia by TCRBV spectratyping

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403297

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403297

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/14973499

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51028658&oldid=2210650256"